| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




* From the Department of Anesthesiology, and
the Department of Surgery, University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA.
Address correspondence to: Dr. J.R. Boyce, UAB Medical Center, Department of Anesthesiology, 619 S. 19th St. Birmingham Al, 35249, USA. Phone: 205-934-7424; Fax: 205-975-1948; E-mail: jboyce{at}uab.edu
| Abstract |
|---|
|
|
|---|
Methods: An Institutional Review Board approved retrospective study was undertaken in 88 patients for whom this technique was selected. The anesthesiologists and surgeons identified as authors were directly involved in the care of these patients. All vessel dilator cricothyrotomies were performed in the operating rooms of University Hospital, UAB, Medical Center. The patients selected for this airway management technique were afflicted with some type of supraglottic lesion, usually squamous cell carcinoma, which was obstructing their airways to an extent that complete airway obstruction during induction of anesthesia was a significant possibility.
Prior to induction of anesthesia, the vessel dilator was inserted into the tracheal lumen through the cricothyroid membrane as described. Oxygenation was maintained with jet ventilation from a Sanders jetting device. Age, sex, weight, initial and lowest O2 saturation, first recorded ETCO2, blood pressure and duration of jet ventilation were recorded.
Results: The airways were successfully managed in all 88 patients with this technique. There were no deaths, and no postoperative hypoxic sequelae; also complications were minor.
Conclusion: Vessel dilator cricothyrotomy as a preemptive procedure in the management of patients with significant supraglottic airway obstruction may be a useful addition to the anesthesiologists armamentarium of airway management devices.
| Introduction |
|---|
|
|
|---|
Otolaryngologists often choose to perform an awake emergency tracheotomy under local anesthesia to resolve this airway problem. However, this emergency airway management procedure has a reported complication rate two to five times higher than a controlled, elective tracheotomy.2,3 Many patients with severe airway obstruction cannot lie still in a supine or even back-up position throughout the procedure, compounding the difficulty of surgical access into the tracheal lumen.
The principle of preemptive cricothyrotomy, as a primary procedure, is to establish a method of oxygenation in these patients with difficult airways due to supraglottic obstruction thereby minimizing the risks of hypoxemia and maximizing the expedient successes of subsequent airway management techniques. This report describes our experience with an elective airway management technique, vessel dilator cricothyrotomy (VDCT), developed by the Department of Anesthesiology and the Division of Otolaryngology-Head and Neck Surgery at the University of Alabama at Birmingham.4
| Methods |
|---|
|
|
|---|
VDCT technique
Patients were placed in a 30° back-up position on the operating room table. Sedation (e.g., midazolam 2 mg iv and ketamine 20 mg iv) was administered, only after all surgical equipment was opened and both anesthesiologist and surgeon were present. Sedation was held until preparation was complete in the operating room to avoid any potential sedation-related airway compromise.
After routine monitors were applied, the anterior neck was prepped and draped. A small roll of towels was placed behind the neck allowing the head to extend, maximizing access to the cricothyroid membrane. Once sedated, patients frequently accepted supplemental oxygen administered by facemask or nasal cannula. A skin wheal over the cricothyroid membrane was made with 2% lidocaine using a 26 G, 5/8" needle on a 10 mL syringe. The same needle, directed caudally, was then used to puncture the cricothyroid membrane in the mid-saggital plane. One to 2 mL of lidocaine were injected into the tracheal lumen. Repeat cricothyroid membrane puncture was performed with a 14 G catheter-over-needle assembly. When free aspiration of air confirmed correct placement, the catheter was advanced and the needle removed. After another test for free air aspiration and injection of additional lidocaine, the guide wire from the dilator set (Cook Critical Care, Bloomingtom, IN, USA.) was inserted into the tracheal lumen through the catheter. The 14-G catheter was removed and the distal end of the guide wire was positioned above the carina to avoid stimulation and coughing paroxysms. The 18-G vessel dilator was then advanced over the guide wire so that 4 to 6 cm of the dilator remained within the tracheal lumen. After removing the guide wire, correct catheter placement was confirmed by a final test of free air aspiration and connecting the gas sampling line from the circle system to detect end-tidal CO2. The vessel dilator, secured to the skin with adhesive tape, was then connected to a Sanders jetting device (Mannujet III VBM Medicintechnic, Lans, Germany) to administer oxygen into the tracheobronchial tree via jet ventilation. To minimize risks of barotrauma, the wall oxygen pressure in the noncompliant tubing of the jetting device was reduced with the in-line reducing valve from 55 to 25 to 30 pounds per square inch for the initial driving pressure. Chest excursion and egress, essential to minimize risks of over-inflation were monitored by watching for chest deflation and listening for sounds of exhalation at the patients mouth (or with a stethoscope to the patients larynx). The oxygen pressure was increased with the reducing valve as needed. At this point, heavy sedation or complete iv induction of anesthesia and full neuromuscular blockade with a nondepolarizing neuromuscular blocker (e.g., rocuronium) was achieved as the neuromuscular blockade increased jet ventilation became more effective. The jetting rate depended on the time required for egress, but 10 to 15 breaths·min1 were average.
| Results |
|---|
|
|
|---|
The average length of time that the VDCT was in place and used as the sole means of airway support was 16.9 min ± 10.4 (ranging from 2 to 66 min). Of the 88 patients who had VDCT performed at the initiation of anesthesia, 66 were subsequently intubated, (58 of 66 had an orotracheal tube placed, and 8 nasal). Of these 66 patients, 27 were successfully extubated, 26 had a tracheotomy placed, and 13 had a laryngectomy with tracheostoma performed. Ten of the patients with an initial VDCT had a tracheotomy performed directly with one of the ten undergoing subsequent laryngectomy. Twelve of the 88 had the VDCT as the sole airway management throughout surgery. These patients underwent direct laryngoscopy with either biopsy or airway debridement with surgical microdebrider and were awakened with the vessel dilator in place. Once adequate airway patency was established, the vessel dilator was removed in the postanesthesia care unit (PACU) prior to transfer to the ward. The morbidly obese patient was successfully intubated by a second anesthesiologist during jet ventilation with VDCT; the lowest oxygen saturation in this patient was 87%.
Oxygen saturations during jet ventilation ranged from 85% to 100% (Table
). One patient was taken emergently to the operating room for tracheotomy to relieve airway obstruction. Prior to VDCT his oxygen saturation was 30% but remained above 92% with jet ventilation through the vessel dilator. Subsequent tracheotomy was performed under total iv anesthesia without incident (Figure
).
|
|
Complications
No patient sustained a pneumothorax based upon clinical signs and symptoms (during and after anesthesia) and chest x-rays performed in the PACU. One patient developed bleeding from the cricothyrotomy puncture site, which resolved with applied pressure for one minute. Two patients who had significant coughing in the PACU, experienced sc emphysema over the anterior neck; this was self-limiting and did not interfere with any of the immediate surgical procedures, but did require unplanned hospital admissions for one night each.
There were no deaths or any significant morbidity resulting from the use of VDCT.
| Discussion |
|---|
|
|
|---|
Successful airway management of the patient with obstructing airway lesions is one of the greatest challenges for anesthesiologists. Adverse outcomes associated with difficult airway management are well illustrated in a report in the Closed Claims Analysis from the Committee on Professional Liability of the American Society of Anesthesiologists. Their findings show that adverse outcomes associated with respiratory events constitute the largest class of injury, with death and brain injury occurring in 85% of those cases.6,7
This review shows that in patients with supraglottic obstructive pathology, preemptive cricothyrotomy with jet ventilation apparatus can provide an oxygenation route directly into the tracheal lumen, bypassing the obstructing lesion. When correct placement of the catheter in the trachea is confirmed, a formal tracheotomy can then be performed below the cricothyrotomy puncture site (Figure
) using iv agents to provide controlled anesthesia. Another option after cricothyrotomy is direct laryngoscopy, performed by the surgeon or the anesthesiologist, for endotracheal intubation. Although the supraglottic pathology often impairs visualization of the glottic aperture, the endoscopist can frequently cannulate the trachea with a small endotracheal tube or a bougie passed into the trachea through the egress site, identified by the appearance of bubbles. A third option is jet ventilation with iv agents as the sole anesthetic technique while the surgeon creates an acceptable airway with an endoscopic microdebrider.8
Cricothyrotomy is not a new concept.9,10 However, it is primarily used by most clinicians as a rescue or emergency technique and this recommendation is supported in the ASA algorithm on management of the difficult airway.1 Although cricothyrotomy is often a relatively simple procedure, abnormal anatomy and a crisis management scenario can magnify all possible difficulties. When preemptively placed under the best conditions possible, success is optimized.
We suggest that the 18-G vessel dilator is optimal for jet ventilation. Although simple iv catheters can be used for transtracheal jet ventilation, they are prone to kinking and compression.11 Further, their short length makes dislodgment a possible risk.12 It should be emphasized that a jet stream produced by a driving pressure of up to 55 psi through a 16 G catheter delivers 500 mL of air per second.13 This gaseous volume delivered subcutaneously outside the tracheal lumen could collapse and totally obstruct the airway, converting a clinical challenge into an airway management disaster. There have been two fatalities at our institution when transtracheal jet ventilation through a 16 G catheter was employed as a rescue maneuver for failed intubation in the emergency room. In both instances, the patients died from airway collapse when the catheters were dislodged from within the tracheal lumen. On the other hand, the vessel dilator is flexible, resists kinking, and has suitable length to be safely positioned in the tracheal lumen with minimal risk of dislodgment. It is not compressible and has an 18-G lumen, which is sufficient for successful jet ventilation. Large patients, such as our heaviest patient weighing 265 kg, often require longer inflation times (1.52 sec) at high pressures (4555 psi).
Most patients with supraglottic pathology causing significant airway obstruction that precludes standard induction of general anesthesia, are candidates for this VDCT. Exclusion criteria include: 1) inaccessibility of the cricothyroid membrane due to edema, obesity, thyroid pathology, or soft tissue extension of laryngo-tracheal tumour, 2) infection at the puncture site and 3) fixed flexion of the head and neck, as occurs with ankylosing spondylitis. Intratracheal pathology at the level of the cricothyroid membrane is a relative contraindication. Patients who have received head and neck radiation often have tissue that is severely indurated. If this has occurred at the cricothyrotomy puncture site in a patient with tumour recurrence obstructing the airway, a VDCT attempt is warranted.
Though this technique has proven to be efficacious and perhaps even life saving in patients with potentially lethal, obstructing airway lesions, both the surgeon and anesthesiologist must be mindful of potential complications. These include puncture of the posterior membranous wall of the trachea leading to sc air or more serious sequelae such as mediastinitis.14 A key concern at the initiation of jet ventilation in patients with severely obstructing tumours is appropriate egress after each jet delivery so that pneumothorax and hypercapnia can be avoided. Careful monitoring of chest deflations and sounds of egress at the mouth or with a stethoscope at the larynx will help prevent these complications.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2 Gillespie MB, Eisele DW. Outcomes of emergency surgical airway procedures in a hospital-wide setting. Laryngoscope 1999; 109: 17669.[Medline]
3 Yarrington CT, Fraser JP. Complications of tracheotomy. Arch Surg 1965; 91: 6525.
4 Boyce JR, Peters G. Vessel dilator cricothyrotomy for transtracheal jet ventilation. Can J Anaesth 1989; 36: 3503.
5 Lang SA, Duncan PG, Shephard DA, Ha HC. Pulmonary oedema associated with airway obstruction. Can J Anaesth 1990; 37: 2108.
6 Caplan RA, Posner KL, Ward RJ, Cheney FW. Adverse respiratory events in anesthesia: a closed claims analysis. Anesthesiology 1990; 72: 82833.[Medline]
7 Schwartz DE, Matthay MA, Cohen NH. Death and other complications of emergency airway management in critically ill adults. Anesthesiology 1995; 82: 36776.[Medline]
8 Simoni P, Peters GE, Magnuson JS, Carroll WR. Use of the endoscopic microdebrider in the management of airway obstruction from laryngotracheal carcinoma. Ann Otol Rhinol Laryngol 2003; 112: 113.[Medline]
9 Jacoby JJ, Hamelberg W, Ziegler CH, Flory FA, Jones JR. Transtracheal resuscitation. JAMA 1956; 162: 6258.
10 Porter Reed J, Kemph JP, Hamelberg W, Hitchcock FA, Jacoby J. Studies with transtracheal artificial respiration. Anesthesiology 1954; 153: 2841.
11 Carden E, Becker G, Hamood H. Percutaneous jet ventilation. Ann Otol Rhinol Laryngol 1976; 85: 6525.[Medline]
12 Weymuller EA, Pavlin EG, Paugh D, Cummings CW. Management of difficult airway problems with percutaneous transtracheal ventilation. Ann Otol Rhinol Laryngol 1987; 96: 347.[Medline]
13 Spoerel WE, Narayanan PS, Singh NP. Transtracheal ventilation. Br J Anaesth 1971; 43: 93240.
14 Wong DT, McGuire GP. Subcutaneous emphysema following trans-cricothyroid membrane injection of local anesthetic. Can J Anesth 2000; 47: 1658.
15 Benumof JL, Scheller MS. The importance of transtracheal jet ventilation in the management of the difficult airway. Anesthesiology 1989; 71: 76978.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |